Median Diagnostics (XKRX:233250) Marketable Securities : ₩4,562 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Median Diagnostics's Marketable Securities for the quarter that ended in Dec. 2024 was ₩4,562 Mil.

Median Diagnostics's annual Marketable Securities increased from Dec. 2022 (₩3,087 Mil) to Dec. 2023 (₩4,094 Mil) and increased from Dec. 2023 (₩4,094 Mil) to Dec. 2024 (₩4,562 Mil).

Median Diagnostics Marketable Securities Historical Data

The historical data trend for Median Diagnostics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics Marketable Securities Chart

Median Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

3,158.33

3,088.88

3,087.49

4,094.35

4,562.41

Median Diagnostics Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Marketable Securities	Get a 7-Day Free Trial					3,158.33	3,088.88	3,087.49	4,094.35	4,562.41

Median Diagnostics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Median Diagnostics (XKRX:233250) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Median Diagnostics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883

Website

http://www.mediandiagnostics.com

Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines